Anti-TNFs found to reduce risk of acute coronary syndrome in rheumatoid arthritis patients

Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research.

Read the whole article on Science Daily

More from Science Daily